Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Stroke

  Free Subscription


16.05.2022

1 Am Heart J
1 Am J Med
2 BMJ
1 BMJ Open
1 Cerebrovasc Dis
2 Eur Heart J
4 J Am Coll Cardiol
1 J Neuroeng Rehabil
1 J Neurosurg
10 J Stroke Cerebrovasc Dis
3 JAMA Neurol
1 Lancet
3 Lancet Neurol
1 Nat Rev Neurol
5 Neurology
2 PLoS One
9 Stroke
2 World Neurosurg


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. HUIJBOOM HFM, Maarse M, Aarnink E, van Dijk VF, et al
    COMPARE LAAO: Rationale and design of the randomized controlled trial 'COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagul
    Am Heart J. 2022 May 7. pii: S0002-8703(22)00085.
    PubMed         Abstract available


    Am J Med

  2. HOLT A, Strange JE, Rasmussen PV, Blanche P, et al
    Bleeding Risk Following Systemic Fluconazole or Topical Azoles in Patients with Atrial Fibrillation on Apixaban, Rivaroxaban, or Dabigatran.
    Am J Med. 2022;135:595-602.
    PubMed         Abstract available


    BMJ

  3. KHAN SU, Yedlapati SH, Lone AN, Hao Q, et al
    PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis.
    BMJ. 2022;377:e069116.
    PubMed         Abstract available

  4. HAO Q, Aertgeerts B, Guyatt G, Bekkering GE, et al
    PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations.
    BMJ. 2022;377:e069066.
    PubMed         Abstract available


    BMJ Open

  5. LARSEN BS, Aplin M, Host N, Dominguez H, et al
    Atrial cardiomyopathy in patients with ischaemic stroke: a cross-sectional and prospective cohort study-the COAST study.
    BMJ Open. 2022;12:e061018.
    PubMed         Abstract available


    Cerebrovasc Dis

  6. LEE SH, Mo HJ, Kim Y, Park SY, et al
    Predicting Role of Prestroke Glycemic Variability Estimated by Glycated Albumin for Reperfusion and Prognosis after Endovascular Treatment.
    Cerebrovasc Dis. 2022 May 10:1-8. doi: 10.1159/000524481.
    PubMed         Abstract available


    Eur Heart J

  7. KANY S, Metzner A, Lubos E, Kirchhof P, et al
    The Atrial Fibrillation Heart Team-guiding therapy in left atrial appendage occlusion with increasingly complex patients and little evidence.
    Eur Heart J. 2022;43:1691-1692.
    PubMed        

  8. HAGEMAN SHJ, McKay AJ, Ueda P, Gunn LH, et al
    Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
    Eur Heart J. 2022;43:1715-1727.
    PubMed         Abstract available


    J Am Coll Cardiol

  9. HOLMES DR JR
    Antithrombotic Therapy After Left Atrial Appendage Occlusion: Cornucopia and Gertrude Stein.
    J Am Coll Cardiol. 2022;79:1799-1801.
    PubMed        

  10. FREEMAN JV, Higgins AY, Wang Y, Du C, et al
    Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2022;79:1785-1798.
    PubMed         Abstract available

  11. WILLEY JZ, Pasterkamp G
    The Role of the Vulnerable Carotid Plaque in Embolic Stroke of Unknown Source.
    J Am Coll Cardiol. 2022 Apr 27. pii: S0735-1097(22)04689.
    PubMed        

  12. KOPCZAK A, Schindler A, Sepp D, Bayer-Karpinska A, et al
    Complicated Carotid Artery Plaques and Risk of Recurrent Ischemic Stroke or TIA.
    J Am Coll Cardiol. 2022 Apr 27. pii: S0735-1097(22)04687.
    PubMed         Abstract available


    J Neuroeng Rehabil

  13. DUFF SV, Miller A, Quinn L, Youdan G Jr, et al
    Quantifying intra- and interlimb use during unimanual and bimanual tasks in persons with hemiparesis post-stroke.
    J Neuroeng Rehabil. 2022;19:44.
    PubMed         Abstract available


    J Neurosurg

  14. KHUNTE M, Wu X, Avery EW, Gandhi D, et al
    Impact of collateral flow on cost-effectiveness of endovascular thrombectomy.
    J Neurosurg. 2022 Apr 29:1-10. doi: 10.3171/2022.2.JNS212887.
    PubMed         Abstract available


    J Stroke Cerebrovasc Dis

  15. INOUE Y, Imura T, Tanaka R, Matsuba J, et al
    Developing a Clinical Prediction Rule for Gait Independence at Discharge in Patients with Stroke: A Decision-Tree Algorithm Analysis.
    J Stroke Cerebrovasc Dis. 2022;31:106441.
    PubMed         Abstract available

  16. MATTHEWS A, Yui J, Chiang EY, Pishko AM, et al
    Cerebral Infarction due to Severe ADAMTS-13 Deficiency with Normal Hematological Parameters: A Cause of Cryptogenic Stroke.
    J Stroke Cerebrovasc Dis. 2022;31:106431.
    PubMed         Abstract available

  17. WANG L, Liu L, Zhao Y, Gao D, et al
    Analysis of Factors Associated with Hemorrhagic Transformation in Acute Cerebellar Infarction.
    J Stroke Cerebrovasc Dis. 2022;31:106538.
    PubMed         Abstract available

  18. NAKAZAKI M, Oka S, Magota H, Kiyose R, et al
    Pharmacological Difference Between Platelet Aggregations in Cardioembolic Stroke Patients with Direct Oral Anticoagulants: A Pilot Study.
    J Stroke Cerebrovasc Dis. 2022;31:106520.
    PubMed         Abstract available

  19. HU L, Liu G, Fan Y
    R558C NOTCH3 Mutation in a CADASIL Patient with Intracerebral Hemorrhage: A Case Report with Literature Review.
    J Stroke Cerebrovasc Dis. 2022;31:106541.
    PubMed         Abstract available

  20. LIU Y, Zhang L, Zhang X, Ma J, et al
    Effect of Combined Vagus Nerve Stimulation on Recovery of Upper Extremity Function in Patients with Stroke: A Systematic Review and Meta-Analysis.
    J Stroke Cerebrovasc Dis. 2022;31:106390.
    PubMed         Abstract available

  21. MANZEKELE BIN KITOKO G, Vivalya BMN, Vagheni MM, Matonda Ma Nzuzi T, et al
    Psychological Burden in Stroke Survivors and Caregivers Dyads at the Rehabilitation Center of Kinshasa (Democratic Republic of Congo): A Cross-Sectional Study.
    J Stroke Cerebrovasc Dis. 2022;31:106447.
    PubMed         Abstract available

  22. MUGISHA S, Job M, Zoppi M, Testa M, et al
    Computer-Mediated Therapies for Stroke Rehabilitation: A Systematic Review and Meta-Analysis.
    J Stroke Cerebrovasc Dis. 2022;31:106454.
    PubMed         Abstract available

  23. HUSSEIN HM, Chrenka EA, Herrmann AA
    Rate and Predictors of Acute Care Encounters in the First Month After Stroke.
    J Stroke Cerebrovasc Dis. 2022;31:106466.
    PubMed         Abstract available

  24. NAGANO F, Yoshimura Y, Matsumoto A, Bise T, et al
    Muscle Strength Gain is Positively Associated with Functional Recovery in Patients with Sarcopenic Obesity After Stroke.
    J Stroke Cerebrovasc Dis. 2022;31:106429.
    PubMed         Abstract available


    JAMA Neurol

  25. NTAIOS G, Omran SS
    Diagnostic Challenges and Uncertainties of Embolic Strokes of Undetermined Source in Young Adults.
    JAMA Neurol. 2022;79:444-447.
    PubMed        

  26. SERLIN Y, Alshahrani M, Frauscher B
    Provocative Hyperventilation in a Patient With Stroke-Like Migraine Attacks After Radiation Therapy.
    JAMA Neurol. 2022;79:526-527.
    PubMed        

  27. WADDELL KJ, Patel MS, Clark K, Harrington TO, et al
    Effect of Gamification With Social Incentives on Daily Steps After Stroke: A Randomized Clinical Trial.
    JAMA Neurol. 2022;79:528-530.
    PubMed        


    Lancet

  28. DELGADO-LISTA J, Alcala-Diaz JF, Torres-Pena JD, Quintana-Navarro GM, et al
    Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial.
    Lancet. 2022 May 4. pii: S0140-6736(22)00122.
    PubMed         Abstract available


    Lancet Neurol

  29. COUTTS SB, Yu AYX
    Tenecteplase for acute stroke: the thrombolysis puzzle.
    Lancet Neurol. 2022 Apr 29. pii: S1474-4422(22)00172.
    PubMed        

  30. KVISTAD CE, Naess H, Helleberg BH, Idicula T, et al
    Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial.
    Lancet Neurol. 2022 Apr 29. pii: S1474-4422(22)00124.
    PubMed         Abstract available

  31. BIVARD A, Zhao H, Churilov L, Campbell BCV, et al
    Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial.
    Lancet Neurol. 2022 Apr 29. pii: S1474-4422(22)00171.
    PubMed         Abstract available


    Nat Rev Neurol

  32. DIENER HC, Easton JD, Hart RG, Kasner S, et al
    Review and update of the concept of embolic stroke of undetermined source.
    Nat Rev Neurol. 2022 May 10. pii: 10.1038/s41582-022-00663.
    PubMed         Abstract available


    Neurology

  33. SPOSATO LA, Andrade J
    Prolonged Cardiac Monitoring for Atrial Fibrillation Detection After Stroke: In Search for the Elusive Sweet Spot.
    Neurology. 2022 Mar 9. pii: WNL.0000000000200333.
    PubMed        

  34. LYONS-WARREN AM, Hirtz D
    More Than a Brain Injury: A Novel Link Between Pediatric Stroke and Autism.
    Neurology. 2022 Mar 25. pii: WNL.0000000000200272.
    PubMed        

  35. BRAEMSWIG TB, Schlemm L, Thomalla G, Endres M, et al
    Author Response: Cerebral Microbleeds and Treatment Effect of Intravenous Thrombolysis in Acute Stroke: An Analysis of the WAKE-UP Randomized Clinical Trial.
    Neurology. 2022;98:817.
    PubMed        

  36. MEINEL TR, Seiffge DJ
    Reader Response: Cerebral Microbleeds and Treatment Effect of Intravenous Thrombolysis in Acute Stroke: An Analysis of the WAKE-UP Randomized Clinical Trial.
    Neurology. 2022;98:816-817.
    PubMed        

  37. GANESH A, Galetta S
    Editors' Note: Cerebral Microbleeds and Treatment Effect of Intravenous Thrombolysis in Acute Stroke: An Analysis of the WAKE-UP Randomized Clinical Trial.
    Neurology. 2022;98:816.
    PubMed        


    PLoS One

  38. QU S, Zhou M, Jiao S, Zhang Z, et al
    Optimizing acute stroke outcome prediction models: Comparison of generalized regression neural networks and logistic regressions.
    PLoS One. 2022;17:e0267747.
    PubMed         Abstract available

  39. BAKO AT, Potter T, Tannous J, Pan AP, et al
    Sex differences in post-stroke cognitive decline: A population-based longitudinal study of nationally representative data.
    PLoS One. 2022;17:e0268249.
    PubMed         Abstract available


    Stroke

  40. ZHOU LW, Lee S, Schwartz NE, Albers GW, et al
    Transient Complete Reversal of Large Area of Restricted Diffusion Seen Early Following Thrombectomy.
    Stroke. 2022 May 6:101161STROKEAHA122038825. doi: 10.1161/STROKEAHA.122.038825.
    PubMed        

  41. KURAMATSU JB, Gerner ST, Ziai WC, Bardutzky J, et al
    Association of intraventricular fibrinolysis with clinical outcomes in ICH: an individual participant data meta-analysis.
    Stroke. 2022 May 6. doi: 10.1161/STROKEAHA.121.038455.
    PubMed         Abstract available

  42. KIM H, Kim JT, Lee JS, Kim BJ, et al
    Stroke of Other Determined Etiology: Results From the Nationwide Multicenter Stroke Registry.
    Stroke. 2022 May 9:101161STROKEAHA121037582. doi: 10.1161/STROKEAHA.121.037582.
    PubMed         Abstract available

  43. NAVE AH, Kaynak N, Mai K, Siegerink B, et al
    Combined Oral Triglyceride and Glucose Tolerance Test After Acute Ischemic Stroke to Predict Recurrent Vascular Events: The Berlin "Cream&Sugar" Study.
    Stroke. 2022 May 9:101161STROKEAHA122038732. doi: 10.1161/STROKEAHA.122.038732.
    PubMed         Abstract available

  44. MEANEY JFM, O'Donnell JS, Bridgewood C, Harbison J, et al
    Perspective: The Case for Acute Large Vessel Ischemic Stroke in COVID-19 Originating Within Thrombosed Pulmonary Venules.
    Stroke. 2022 May 11:101161STROKEAHA121038056. doi: 10.1161/STROKEAHA.121.038056.
    PubMed         Abstract available

  45. MUN KT, Bonomo JB, Liebeskind DS, Saver JL, et al
    Fragility Index Meta-Analysis of Randomized Controlled Trials Shows Highly Robust Evidential Strength for Benefit of <3 Hour Intravenous Alteplase.
    Stroke. 2022 May 11:101161STROKEAHA121038153. doi: 10.1161/STROKEAHA.121.038153.
    PubMed         Abstract available

  46. PIRSON FAVA, Boodt N, Brouwer J, Bruggeman AAE, et al
    Etiology of Large Vessel Occlusion Posterior Circulation Stroke: Results of the MR CLEAN Registry.
    Stroke. 2022 May 11:101161STROKEAHA121038054. doi: 10.1161/STROKEAHA.121.038054.
    PubMed         Abstract available

  47. LI W, Huang Z, Fang W, Wang X, et al
    Remnant Cholesterol Variability and Incident Ischemic Stroke in the General Population.
    Stroke. 2022 May 11:101161STROKEAHA121037756. doi: 10.1161/STROKEAHA.121.037756.
    PubMed         Abstract available

  48. PACIARONI M, Caso V, Agnelli G, Mosconi MG, et al
    Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study.
    Stroke. 2022 May 11:101161STROKEAHA121038239. doi: 10.1161/STROKEAHA.121.038239.
    PubMed         Abstract available


    World Neurosurg

  49. LU Z, Li S, Tang H, Zhu S, et al
    Effect of proximal parent artery stenosis on the outcomes of posterior communicating artery aneurysms: A preliminary study based on case-specific hemodynamic analysis.
    World Neurosurg. 2022 May 5. pii: S1878-8750(22)00554.
    PubMed         Abstract available

  50. JANG J, Lee JK, Koo J, Kim BS, et al
    Acute Ischemic Stroke caused by Internal Carotid Artery Occlusion: Impact of Occlusion Type on the Prognosis.
    World Neurosurg. 2022 May 2. pii: S1878-8750(22)00564.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: